With an aim to provide end-to-end testing solutions, one of India’s leading and
renowned diagnostic companies, Metropolis Healthcare Ltd has begun testing for Covid-19 in the state of Tamil Nadu.
The Metropolis lab in Tamil Nadu has recently received the ICMR and NABL approval and has been conducting tests since 10 plus years at its lab in Coimbatore. Additionally, Metropolis has seven other labs in the country that is already approved for Covid-19 testing at Mumbai, Pune, Thane, Chennai, Cochin, Delhi, and Bangalore.
Sharing her views on the same, Dr Anita Suryanaryanan, Vice President, Metropolis Healthcare Ltd said, “In addition to Chennai, we are happy to announce that we now have also begun testing for Covid-19 using TrueNat technology at the Coimbatore lab. Metropolis has been at the forefront of this pandemic since day one conducting thousands of tests across our eight COVID capable labs. A warm patient-centric approach, technological superiority, and reliable diagnostic reports have made Metropolis one of the preferred labs which have been further proved in this pandemic.”
How does TrueNat work?
RT PCR or reverse transcriptase-polymerase chain reaction is a method that includes capturing specific genes from the extracted RNA from the sample. A small part of specific RNA is converted to DNA, and then it is amplified to a large amount through a series of chemical processes. TrueNat is a chip-based, battery-operated RT-PCR kit. The new
TrueNat machines are equipped to detect the E genes and RdRp genes separately from the virus RNA, and hence these tests are treated as a confirmation for the presence of the novel coronavirus.